Mycobacterial Characteristics and Treatment Outcomes in Mycobacterium abscessus Lung Disease.
about
Clofazimine-Containing Regimen for the Treatment of Mycobacterium abscessus Lung Disease.Clinical Characteristics and Treatment Outcomes of Patients with Acquired Macrolide-resistant Mycobacterium abscessus Lung Disease.Pediatric Dental Clinic-Associated Outbreak of Mycobacterium abscessus Infection.Antagonism between Front-Line Antibiotics Clarithromycin and Amikacin in the Treatment of Mycobacterium abscessus Infections Is Mediated by the whiB7 Gene.Systematic review and meta-analyses of the effect of chemotherapy on pulmonary Mycobacterium abscessus outcomes and disease recurrence.Long-term Outcome of Pulmonary Resection for Nontuberculous Mycobacterial Pulmonary Disease.Trehalose Polyphleates, External Cell Wall Lipids in Mycobacterium abscessus, Are Associated with the Formation of Clumps with Cording Morphology, Which Have Been Associated with Virulence.Risk factors for the development of chronic pulmonary aspergillosis in patients with nontuberculous mycobacterial lung disease.Antimicrobial resistance in Mycobacterium abscessus complex isolated from patients with skin and soft tissue infections at a tertiary teaching hospital in Taiwan.Nontuberculous mycobacteria in cystic fibrosis: Updates and the path forward.Mycobacterium abscessus Complex Infections: A Retrospective Cohort Study.Changing Epidemiology of Nontuberculous Mycobacterial Lung Diseases in a Tertiary Referral Hospital in Korea between 2001 and 2015.NTM drug discovery: status, gaps and the way forward.A Simple and Rapid Gene Disruption Strategy in Mycobacterium abscessus: On the Design and Application of Glycopeptidolipid Mutants.The Clarithromycin Susceptibility Genotype Affects the Treatment Outcome of Patients with Mycobacterium abscessus Lung Disease.Prevention of aerosol isolation of nontuberculous mycobacterium from the patient's bathroom.Novel Screen to Assess Bactericidal Activity of Compounds Against Non-replicating
P2860
Q38404398-792CF529-32E0-43D5-A254-B3F6A6E60FD5Q38663720-286CFECE-F01C-4E4D-A2F7-7BDACDB440B5Q40043013-48FF2052-03BE-40E9-A8C5-F7F89A288828Q40065950-2E733691-897B-4BBE-B251-4DC098795B85Q40093562-3F333C65-40AB-42AF-BF3F-8E7623D614EEQ40267623-A81718F2-5F76-4D57-87E4-75516D2AD531Q41108337-EE9687FF-46C1-4097-8A84-476DAE8BC95FQ47127168-740CF99D-25C7-4901-89E4-697143229BE6Q47677714-89CE26A8-FCA7-4963-A449-C22C11CBA9EFQ47960948-FD2196F4-6A48-4D23-808B-069657535A5AQ49622474-512794FD-FF56-4A4E-9AD3-EBDA58703E52Q50019507-8A008D79-A45F-411E-AAE4-9FA8E563D8BEQ52596288-CFA1117C-7A4B-48E0-9CF2-D7389126C829Q52690344-AD1CB152-A7F1-4EBE-885F-318852277FB4Q54943989-1E9720A2-EF80-47F7-84E6-CCF90FBEF205Q55447000-6D637F5A-89EB-4284-A42F-5EB5FAA69FC6Q58575893-7DFC6CD5-6979-46BA-9989-38C5DCD26C32
P2860
Mycobacterial Characteristics and Treatment Outcomes in Mycobacterium abscessus Lung Disease.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Mycobacterial Characteristics ...... terium abscessus Lung Disease.
@en
type
label
Mycobacterial Characteristics ...... terium abscessus Lung Disease.
@en
prefLabel
Mycobacterial Characteristics ...... terium abscessus Lung Disease.
@en
P2093
P2860
P50
P356
P1476
Mycobacterial Characteristics ...... cterium abscessus Lung Disease
@en
P2093
Byung Woo Jhun
Chang Ki Kim
Chang-Seok Ki
Charles L Daley
Dae Hun Kim
Hojoong Kim
Hong Kwan Kim
Hye Yun Park
Jhingook Kim
P2860
P304
P356
10.1093/CID/CIW724
P407
P577
2016-11-10T00:00:00Z